In a move that could expand access to popular weight-loss medications, Novo Nordisk is partnering with Costco. The agreement will allow Costco members to purchase the drugs Wegovy and Ozempic at nearly half the current price.
The significant discount applies specifically to customers who pay for the medications out-of-pocket. This directly benefits individuals whose insurance does not cover these treatments.
The partnership was reported by NBC News. The report did not specify an exact start date for the new pricing.
This development comes as demand for GLP-1 receptor agonists like Wegovy and Ozempic remains high. These drugs have proven effective for weight management and treating type 2 diabetes. However, their high cost has been a major barrier for many patients.
The collaboration between the pharmaceutical giant and the wholesale retailer could make these treatments more affordable for millions of Americans. It represents a significant shift in the market for prescription weight-loss drugs.
Related topics:
